Delivery Order SPE2DB22D3004-SPE2DB25FRY69
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets in quantities of 100 units. This is a competitively awarded, firm fixed price contract with no set-aside designation, valued at $1,474.20 and scheduled for completion by August 29, 2025. The product will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,040.73 to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets (100-count) on May 12, 2025, with an ultimate completion date of May 13, 2025. This firm fixed-price, non-competitive delivery order represents a single pharmaceutical supply transaction under AmerisourceBergen's broader federal contract portfolio. The product will be delivered to the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets in quantities of 100 units, with a contract ceiling value of $1,228.50. This delivery order represents a firm fixed-price transaction with no set-aside designation, indicating competitive award. The contract is classified as a child action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,258.58 delivery order to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (500 count) on July 31, 2025, with completion expected by August 1, 2025. This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,997.78 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Butalbital-Acetaminophen-Caffeine-Codeine 50-300mg tablets (100 count). This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a competitive award with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $1,445.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Butalbital-Aspirin-Caffeine tablets (90-count). This non-set-aside contract was awarded competitively and has an ultimate completion date of September 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,032.63 to AmerisourceBergen Drug Corp for Butalbital-Aspirin-Caffeine 90-count tablets, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement issued on August 4, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $4,394.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Butalbital-Acetaminophen-Caffeine-Codeine 50-300mg in 100-count units. This non-set-aside contract was awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a $78.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 units of Butalbital-Aspirin-Caffeine combination pills. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 30, 2023 under the terms of the order. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor and...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563589269 - BUTALBITAL-ASPIRIN-CAFFEINE CP 100S, a pharmaceutical product. The award has a potential value of $1,100.08 and a performance period through February 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with the Defense Logistics Agency with a potential value of...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRY69Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,538.79 to AmerisourceBergen Drug Corp for the supply of Butalbital-Acetaminophen-Caffeine 50-300-40mg tablets in a quantity of 100 units. This non-competitive, firm fixed-price delivery order was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award represents a child contract issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as the primary vehicle for supplying pharmaceuticals and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant position within the federal medical procurement landscape as a critical supplier to military and veteran healthcare systems. The company was awarded this delivery order through open competition without set-aside designation, consistent with its established contracting pattern with the Defense Logistics Agency. The underlying IDC encompasses a comprehensive portfolio of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/12/25 |